Quetiapine Poisoning: A Case Series

Annals of Emergency Medicine

Volumn 42, Issue 6, 2003, Pages 751-758

  Balit, Corrine R ^a   Isbister, Geoffrey K ^b,c   Hackett, L Peter ^d   Whyte, Ian M ^b,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c NEWCASTLE MATER HOSPITAL   (Australia)

^d Western Australian Centre for Pathology and Medical Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTOXIN; QUETIAPINE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DEPRESSION; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DELIRIUM; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG INTOXICATION; DRUG OVERDOSE; ELECTROCARDIOGRAM; FEMALE; GLASGOW COMA SCALE; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INGESTION; INTENSIVE CARE UNIT; INTUBATION; LENGTH OF STAY; MALE; MYDRIASIS; PRIORITY JOURNAL; QT PROLONGATION; RESPIRATION DEPRESSION; SEIZURE; SINUS TACHYCARDIA; TACHYCARDIA;

EID: 0345258011     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-0644(03)00600-0     Document Type: Article

References (29)

1. Borison RL, Arvanitis LA, Miller BG. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US SEROQUEL Study Group. J Clin Psychopharmacol. 1996;16:158-169.
2. DeVane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet. 2001;40:509-522.
3. Pollak PT, Zbuk K. Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions. Clin Pharmacol Ther. 2000;68:92-97.
4. Hustey FM. Acute quetiapine poisoning. J Emerg Med. 1999;17:995-997.
5. Harmon TJ, Benitez JG, Krenzelok EP, et al. Loss of consciousness from acute quetiapine overdosage. J Toxicol Clin Toxicol. 1998;36:599-602.
6. Gajwani P, Pozuelo L, Tesar GE. QT interval prolongation associated with quetiapine (Seroquel) overdose. Psychosomatics. 2000;41:63-65.
7. Nudelman E, Vinuela LM, Cohen CI. Safety in overdose of quetiapine: a case report [letter]. J Clin Psychiatry. 1998;59:433
8. Juhl GA, Benitez JG, McFarland S. Acute quetiapine overdose in an eleven-year, old girl. Vet Hum Toxicol. 2002;44:163-164.
9. Lynch S, Fill S, Hoffman RS Intentional quetiapine (seroquel) overdose [abstract]. J Toxicol Clin Toxicol. 1999;37:631.
10. Mowry J, Sanftleben J, Smith J. Eighteen month retrospective evaluation of seroquel exposures [abstract]. J Toxicol Clin Toxicol. 1999;37:631.
11. Pais VM, Ayvazian PJ. Priapism from quetiapine overdose: first report and proposal of mechanism. Urology. 2001;58:462vii-462viii.
12. Whyte IM, Buckley NA, Dawson AH. Data collection in clinical toxicology: are there too many variables? J Toxicol Clin Toxicol. 2002;40:223-230.
13. Buckley NA, Whyte IM, Dawson AH, et al. Preformatted admission charts for poisoning admissions facilitate clinical assessment and research. Ann Emerg Med. 1999;34(4 Pt 1):476-482.
14. Bazett H. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353-370.
15. Isbister GK, Dawson A, Whyte IM. Cardiac toxicity of citalopram and other selective serotonin reuptake inhibitors in overdose [abstract]. Emerg Med. 2001;14:A33.
16. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 1993;72:23B-25B.
17. Burns MJ. The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol. 2001;39:1-14.
18. Reith DM, Monteleone JP, Whyte IM, et al. Features and toxicokinetics of clozapine in overdose. Ther Drug Monit. 1998;20:92-97.
19. Isbister GK, Balit CR, Dawson AH, et al. Valproate overdose: a comparative cohort study of self poisonings. Br J Clin Pharmacol. 2003;55:398-404.
20. Dev V, Raniwalla J. Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf. 2000;23:295-307.
21. Buckley NA, Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Saf. 2000;23:215-228.
22. Geddes J, Freemantle N, Harrison P, et al, and the National Schizophrenia Guideline Development Group. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000;321:1371-1376.
23. Hodges M. Rate correction of the QT interval. Card Electrophysiol Rev. 1997;3:360-363.
24. Hnatkova K, Malik M. "Optimum" formulae for heart rate correction of the QT interval. Pacing Clin Electrophysiol. 1999;22:1683-1687.
25. Al Khatib SM, LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA. 2003;289:2120-2127.
26. Malik M, Camm AJ. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug Saf. 2001;24:323-351.
27. Isbister GK, Balit CR. Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother. 2003;37:999-1002.
28. Isbister GK, Whyte IM. Atypical presentation of risperidone toxicity. Vet Hum Toxicol. 2002;44:118-119.
29. Chyka PA, Seger D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35:721-741.